Abbott sues ex-employee over COVID-19 tests

Abbott Laboratories has asked an Illinois court to halt a former employee from using its name and trademarks to sell COVID-19 diagnostic tests.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

COVID-19 spurs medical and pharma rise in ‘Top 100 Global Innovators’ report

23 February 2021 Innovation by medical and pharma sectors has increased over the past year in the wake of the pandemic, a new report by IP services company Clarivate has confirmed.

Big Pharma

Quercis licenses patents for thromboembolism platform

28 January 2021 Biopharmaceutical company, Quercis Pharma, has exclusively licensed two patents to enhance its ability to provide approved treatments for COVID-19 and cancer.

Big Pharma

Abbott gets restraining order against ex-VP in COVID-19 trade secrets dispute

5 November 2020 Biopharmaceutical company, Abbott Laboratories, has successfully obtained a restraining order against its former vice-president of global marketing, whom it has accused of stealing trade secrets relating to COVID-19 products.

More on this story

Big Pharma

COVID-19 spurs medical and pharma rise in ‘Top 100 Global Innovators’ report

23 February 2021 Innovation by medical and pharma sectors has increased over the past year in the wake of the pandemic, a new report by IP services company Clarivate has confirmed.

Big Pharma

Quercis licenses patents for thromboembolism platform

28 January 2021 Biopharmaceutical company, Quercis Pharma, has exclusively licensed two patents to enhance its ability to provide approved treatments for COVID-19 and cancer.

Big Pharma

Abbott gets restraining order against ex-VP in COVID-19 trade secrets dispute

More on this story

Big Pharma

COVID-19 spurs medical and pharma rise in ‘Top 100 Global Innovators’ report

23 February 2021 Innovation by medical and pharma sectors has increased over the past year in the wake of the pandemic, a new report by IP services company Clarivate has confirmed.

Big Pharma

Quercis licenses patents for thromboembolism platform

28 January 2021 Biopharmaceutical company, Quercis Pharma, has exclusively licensed two patents to enhance its ability to provide approved treatments for COVID-19 and cancer.

Big Pharma

Abbott gets restraining order against ex-VP in COVID-19 trade secrets dispute